On February 5, 2020, Judge Andrew Y.S. Cheng of the Superior Court for the County of San Francisco issued an order appointing Lieff Cabraser partner Sarah R. London to the Plaintiffs’ Executive Committee in the Gilead HIV Drug Kidney & Bone Injuries Litigation. Sarah will lead the litigation on behalf of patients across California who allege they suffered kidney and bone injuries from HIV drugs made and distributed by pharmaceutical giant Gilead Sciences, Inc.
In the litigation, patients claim that the drugs they were provided were more harmful derivatives than other, newer drugs the company had created but would not sell until its stock of the more harmful drugs was exhausted. These first-in-the-nation lawsuits against Gilead seek damages and other remedies for personal injuries stemming from the ingestion of Gilead’s prescription medications (Truvada® and Atripla®) that contain tenofovir disoproxil fumarate (“TDF”). Plaintiffs allege that Gilead knew or should have known of a safer alternative design for its TDF-containing drugs, and that Gilead failed to adequately warn of the known and knowable risks associated with its medications. The lawsuit alleges causes of action for strict products liability, negligent products liability, breach of implied warranty, and breach of express warranty.
Learn more about the Gilead HIV Drug Kidney & Bone Injuries Litigation
Contact National Drug Injury Attorneys
If you believe you have suffered kidney or bone injury relating to Gilead HIV drugs you were led to take with insufficient warnings because Gilead delayed selling its safer and better HIV drugs until it could sell all of its earlier more harmful drugs, please contact Lieff Cabraser partner Sarah London today at 1 800 541-7358 or by using the form on this page to talk about your case and potential recovery. There is no charge for our review of your case, and all information you provide will be held in the strictest confidence.
About Sarah London
A member of the Consumer Attorneys of California Convention Leadership Committee and a partner in Lieff Cabraser’s San Francisco office, Sarah London is a determined, skilled, and experienced advocate for the injured, employees, and consumers. She is experienced in all aspects of trial work, from drafting and arguing motions in limine, opposing Daubert challenges to plaintiffs’ experts and deposing defendants’ experts, and serving as lead trial counsel to writing successful post-trial and appellate briefs. Sarah’s case work involvement includes: the Florida Tobacco litigation, Zofran Infant Injury lawsuits, the Toyota Sudden Acceleration litigation, the Norvir antitrust case, and Pacific Fertility Clinic Egg and Embryo Preservation Failures. A Super Lawyers Rising Star for five consecutive years and 2015 finalist for the Consumer Attorneys of California Streetfighter of the Year Award, Sarah has held multiple leadership positions in CAOC.